LEADER 01213nam0-2200349 --450 
001 9910349859303321
005 20191129100436.0
010   $a9781455746927
010   $a9996097102
010   $a9996097161 (v. 2 : alk. paper)
035   $a(DNLM)101631364
100   $a20191128d2016----kmuy0itay5050    ba
101 0 $aeng
200 1 $aSleisenger and Fordtran's gastrointestinal and liver disease$epathophysiology diagnosis management$fMark Feldman, Lawrence S. Friedman, Lawrence J. Brandt
205   $a10th ed.
210  1$aPhiladelphia, PA$cSaunders Elsevier$d[2016]
215   $a2 v. (xxxi, 2369, 89 pages)$d29 cm
517 1 $aGastrointestinal and liver disease
610 0 $aGastrointestinal Diseases
610 0 $aLiver Diseases
676   $a616.3/3
702  1$aFeldman,$bMark$f<1947- >
702  1$aFriedman,$bLawrence S.$g(Lawrence Samuel),$f<1953- >
702  1$aBrandt,$bLawrence J.
801  0$aIT$bUNINA$gREICAT$2UNIMARC
901   $aBK
912   $a9910349859303321
952   $a90 R 4a 37 I$b285/2019$fFMEBC
952   $a90 R 4a 37 II$b286/2019$fFMEBC
959   $aFMEBC
996   $aSleisenger and Fordtran's gastrointestinal and liver disease$91566561
997   $aUNINA